Walter Stockinger
Inversor de Capital Privado en Hadean Ventures AS .
Cargos activos de Walter Stockinger
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Hadean Ventures AS
 Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Inversor de Capital Privado | 01/05/2016 | - |
Historial de carrera de Walter Stockinger
Antiguos cargos conocidos de Walter Stockinger.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Director/Miembro de la Junta | - | - |
| Director de Inversiones | - | - |
Formación de Walter Stockinger.
| University of Vienna | Doctorate Degree |
Estadísticas
Internacional
| Irlanda | 2 |
| Austria | 2 |
| Noruega | 2 |
Operativa
| Director/Board Member | 1 |
| Chief Investment Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
Hadean Ventures AS
Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Finance |
- Bolsa de valores
- Insiders
- Walter Stockinger
- Experiencia
